Mingxi Li

TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway

Hongtao Xu, Xuezhu Rong, Xiaoqian Zhang, 2023, Oncology reports.